4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000015
CEO gave up 17,566 shares (to pay taxes)
- CEO acquired 116,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Doshi Dipal · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-01 | Grant or award : show line 1 in the form | +116,200 | 441,953 | D | ||
| 2025-03-03 | Shares withheld for taxes : show line 2 in the form | −17,566 | $11.68 | $205,146 | 424,387 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-01 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +173,400 | 173,400 | D |
Loading xslF345X05/wk-form4_1741125701.xml…